Format

Send to

Choose Destination
Ugeskr Laeger. 2010 Mar 15;172(11):852-7.

[Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents].

[Article in Danish]

Author information

1
Anaestesiologisk og Intensiv Afdeling, Hvidovre Hospital, DK-2650 Hvidovre, Denmark. mattisboy@webspeed.dk

Abstract

Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.

PMID:
20403266
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center